-- 根據週二提交給新加坡交易所的文件，Fortress Minerals（SGX：OAJ）截至2月28日的第四財季實現歸屬於股東的利潤902,953新元，而去年同期則虧損974,379新元。 這家礦產勘探公司的股價在周三早盤交易中上漲了4%。 每股收益為0.0017新元，去年同期每股虧損0.0019新元。 營收年減25%，從1800萬美元降至1350萬美元。
Related Articles
Research
Research Alert: Gsk Q1 Beat As Specialty Medicines Remains Strong, Reiterates 2026 Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GSK delivered a Q1 2026 beat with sales growing 2% Y/Y (5% CER), led by Specialty Medicines (+10% or +14% CER), particularly oncology with strong Jemperli and Ojjaara uptake, while Vaccines grew 4% CER on record Shingrix sales. Core EPS grew 4% or 9% CER to GBP0.465, ahead of the consensus of GBP0.44, supported by a favorable product mix and cost control that lifted the core operating margin by 1.0%-pt or 1.8%-pts CER. We view the Q1 update positively given the beat and margin expansion, though we are mindful of currency headwinds. GSK reiterated its 2026 guidance for 3%-5% sales growth and 7%-9% core operating profit growth (CER), which is broadly aligned with that of several peers like Sanofi and Roche despite implying slower growth versus 2025. We expect revenue to be supported by key Specialty Medicines products, with GSK targeting the segment to contribute more than 50% of sales by 2031 (Q1 2026: 42%), while recent acquisitions provide a much-needed boost to growth and the drug pipeline, in our view.
$GSK
International
Thailand Keeps Policy Rate Steady at 1%, as Expected
The Bank of Thailand's Monetary Policy Committee unanimously voted to keep the policy rate unchanged at 1%, as expected by analysts, according to a Wednesday press release.The committee said Thailand's economy is expected to slow as the Middle East conflict drives up costs, weakens household purchasing power and adds uncertainty to the outlook.While earlier data showed stronger-than-expected growth supported by domestic demand and exports, GDP is now projected to ease to 1.5% in 2026 and 2.0% in 2027 due to war-related impacts.Private consumption is expected to come under pressure from higher living costs and weaker incomes, while tourism arrivals may also decline. Export growth, however, is expected to remain supported by global demand for tech products. Inflation is projected to average 2.9% in 2026 before easing to 1.5% in 2027 as supply pressures fade, the central bank said.
$^SET
Research
Research Alert: Ubs Q1 Beats On Integration And Ib Strength; Capital Requirements Cloud Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UBS delivered exceptional Q1 2026 results with net profit of USD3.0B (+80% Y/Y) and underlying PBT of USD4.0B (+54% Y/Y), beating consensus estimates. The strong performance reflected broad-based momentum, with underlying revenues advancing 18% and the fourth consecutive quarter of positive operating leverage. UBS achieved a pivotal milestone in the Credit Suisse integration, completing Swiss client account transfers and delivering USD0.8B in additional gross cost savings. Management expressed confidence in substantially completing the integration by year-end 2026 and achieving exit rate targets of an underlying return on CET1 capital of approximately 15% and a cost-to-income ratio below 70%. However, two significant overhangs temper the outlook: proposed Swiss capital framework changes requiring an additional USD22B in CET1 capital represent a material headwind, while elevated geopolitical risks could shift client sentiment given management's guidance for flat net interest income sequentially in Q2 2026.
$UBS